XML 114 R17.htm IDEA: XBRL DOCUMENT v2.4.0.6
FINANCIAL INSTRUMENTS
62 Months Ended
Dec. 31, 2012
FINANCIAL INSTRUMENTS

H.    FINANCIAL INSTRUMENTS

Cash Equivalents

Teradyne considers all highly liquid investments with maturities of three months or less at the date of acquisition to be cash equivalents.

 

Marketable Securities

Teradyne accounts for its investments in debt and equity securities in accordance with the provisions of ASC 320-10, “Investments—Debt and Equity Securities.” ASC 320-10 requires that certain debt and equity securities be classified into one of three categories; trading, available-for-sale or held-to-maturity securities. On a quarterly basis, Teradyne reviews its investments to identify and evaluate those that have an indication of a potential other-than-temporary impairment. Factors considered in determining whether a loss is other-than-temporary include:

 

   

The length of time and the extent to which the market value has been less than cost;

 

   

The financial condition and near-term prospects of the issuer; and

 

   

The intent and ability to retain the investment in the issuer for a period of time sufficient to allow for any anticipated recovery in market value.

Teradyne uses the market and income approach techniques to value its financial instruments and there were no changes in valuation techniques during the years ended December 31, 2012, 2011 and 2010. As defined in ASC 820-10 “Fair Value Measurements and Disclosures”, fair value is the price that would be received from the sale of an asset or paid to transfer a liability in an orderly transaction between market participants. ASC 820-10 requires that assets and liabilities carried at fair value be classified and disclosed in one of the following three categories:

Level 1: Quoted prices in active markets for identical assets as of the reporting date.

Level 2: Inputs other than Level 1, that are observable either directly or indirectly as of the reporting date. For example, a common approach for valuing fixed income securities is the use of matrix pricing. Matrix pricing is a mathematical technique used to value securities by relying on the securities’ relationship to other benchmark quoted prices, and therefore is considered a Level 2 input.

Level 3: Unobservable inputs that are not supported by market data. Unobservable inputs are developed based on the best information available, which might include Teradyne’s own data.

Most of Teradyne’s fixed income securities are classified as Level 2, with the exception of U.S. Treasury securities and investments in equity and debt mutual funds, which are classified as Level 1, and contingent consideration, which is classified as Level 3. The majority of Level 2 securities are priced by third party pricing vendors. These pricing vendors utilize the most recent observable market information in pricing these securities or, if specific prices are not available, use other observable inputs like market transactions involving identical or comparable securities.

There were no realized losses recorded in 2012, 2011 and 2010. Realized gains recorded in 2012, 2011 and 2010 were $1.4 million, $2.7 million and $3.2 million, respectively. Realized gains are included in interest income. Unrealized gains and losses are included in accumulated other comprehensive income (loss). The cost of securities sold is based on the specific identification method.

During the years ended December 31, 2012 and 2011, there were no transfers in or out of Level 1, Level 2 or Level 3 financial instruments.

 

The following table sets forth by fair value hierarchy Teradyne’s financial assets and liabilities that were measured at fair value on a recurring basis as of December 31, 2012 and 2011.

 

     December 31, 2012  
     Quoted Prices
in Active
Markets for
Identical
Instruments
(Level 1)
     Significant
Other
Observable
Inputs
(Level 2)
     Significant
Unobservable
Inputs
(Level 3)
     Total  
     (in thousands)  

Assets

           

Cash

   $ 139,354       $      $      $ 139,354   

Cash equivalents

     183,039         16,527                199,566   

Available for sale securities:

           

U.S. Treasury securities

     312,116                       312,116   

U.S. government agency securities

            217,655                217,655   

Commercial paper

            70,434                70,434   

Corporate debt securities

            55,755                55,755   

Equity and debt mutual funds

     9,717                       9,717   

Certificates of deposit and time deposits

            1,627                1,627   

Non-U.S. government securities

            84               84   
  

 

 

    

 

 

    

 

 

    

 

 

 

Total

     644,226         362,082                1,006,308   

Derivatives

             121                121   
  

 

 

    

 

 

    

 

 

    

 

 

 

Total

   $ 644,226       $ 362,203       $      $ 1,006,429   
  

 

 

    

 

 

    

 

 

    

 

 

 

Liabilities

           

Contingent consideration

   $      $      $ 388       $ 388   
  

 

 

    

 

 

    

 

 

    

 

 

 

Total

   $      $      $ 388       $ 388   
  

 

 

    

 

 

    

 

 

    

 

 

 

Reported as follows:

 

     (Level 1)      (Level 2)      (Level 3)      Total  
     (in thousands)  

Assets

           

Cash and cash equivalents

   $ 322,393       $ 16,527       $      $ 338,920   

Marketable securities

     239,192         192,324                431,516   

Long-term marketable securities

     82,641         153,231                235,872   

Prepayments and other current assets

             121                121   
  

 

 

    

 

 

    

 

 

    

 

 

 
   $ 644,226       $ 362,203       $      $ 1,006,429   
  

 

 

    

 

 

    

 

 

    

 

 

 

Liabilities

           

Contingent consideration

   $      $      $ 388       $ 388   
  

 

 

    

 

 

    

 

 

    

 

 

 
   $      $      $ 388       $ 388   
  

 

 

    

 

 

    

 

 

    

 

 

 

 

     December 31, 2011  
     Quoted Prices
in Active
Markets for
Identical
Instruments
(Level 1)
     Significant
Other
Observable
Inputs
(Level 2)
     Significant
Unobservable
Inputs
(Level 3)
     Total  
     (in thousands)  

Assets

           

Cash

   $ 161,243       $      $      $ 161,243   

Cash equivalents

     396,329         16,164                412,493   

Available for sale securities:

           

U.S. government agency securities

            83,197                83,197   

Corporate debt securities

            44,829                44,829   

Commercial paper

            22,075                22,075   

U.S. Treasury securities

     14,180                       14,180   

Equity and debt mutual funds

     8,237                       8,237   

Certificates of deposit and time deposits

            8,117                8,117   

Non-U.S. government securities

             274               274   
  

 

 

    

 

 

    

 

 

    

 

 

 

Total

   $ 579,989       $ 174,656       $      $ 754,645   
  

 

 

    

 

 

    

 

 

    

 

 

 

Liabilities

           

Derivatives

   $      $ 314       $      $ 314   

Contingent consideration

                   68,892         68,892   
  

 

 

    

 

 

    

 

 

    

 

 

 

Total

   $      $ 314       $ 68,892       $ 69,206   
  

 

 

    

 

 

    

 

 

    

 

 

 

Reported as follows:

 

     (Level 1)      (Level 2)      (Level 3)      Total  
     (in thousands)  

Assets

           

Cash and cash equivalents

   $ 557,572       $ 16,164       $      $ 573,736   

Marketable securities

     9,044         87,458                96,502   

Long-term marketable securities

     13,373         71,034                84,407   
  

 

 

    

 

 

    

 

 

    

 

 

 
   $ 579,989       $ 174,656       $      $ 754,645   
  

 

 

    

 

 

    

 

 

    

 

 

 

Liabilities

           

Other accrued liabilities

   $      $ 314       $      $ 314   

Contingent consideration

                   68,892         68,892   
  

 

 

    

 

 

    

 

 

    

 

 

 
          $ 314       $ 68,892       $ 69,206   
  

 

 

    

 

 

    

 

 

    

 

 

 

Changes in the fair value of Level 3 contingent consideration for the year ended December 31, 2012 and December 31, 2011 were as follows:

 

     Contingent Consideration  
     (in thousands)  

Balance at December 31, 2010

   $  

Acquisition of LitePoint

     68,892   
  

 

 

 

Balance at December 31, 2011

     68,892   

Fair value adjustment

     (8,794

Payments

     (59,710
  

 

 

 

Balance at December 31, 2012

   $ 388   
  

 

 

 

 

The carrying amounts and fair values of financial instruments at December 31, 2012 and 2011 were as follows:

 

     December 31, 2012      December 31, 2011  
     Carrying Value      Fair Value      Carrying Value      Fair Value  
     (in thousands)  

Cash and cash equivalents

   $ 338,920       $ 338,920       $ 573,736       $ 573,736   

Marketable securities

     667,388         667,388         180,909         180,909   

Convertible debt (1)

     169,896         589,000         156,098         485,925   

Japan loan

     3,491         3,491         6,431         6,431   

 

(1) The carrying value represents the bifurcated debt component only, while the fair value is based on quoted market prices for the convertible note which includes the equity conversion feature.

The fair values of cash and cash equivalents, accounts receivable, net and accounts payable approximate the carrying amount due to the short term maturities of these instruments.

The following tables summarize the composition of available for sale marketable securities at December 31, 2012 and 2011:

 

    December 31, 2012  
    Available-for-Sale     Fair Market
Value of Investments
with Unrealized  Losses
 
    Cost     Unrealized
Gain
    Unrealized
(Loss)
    Fair Market
Value
   
    (in thousands)  

U.S. Treasury securities

  $ 311,915      $ 216      $ (15 )   $ 312,116      $ 1,018  

U.S. government agency securities

    217,396        262        (3     217,655        9,018   

Commercial paper

    70,431        9        (6     70,434        25,209   

Corporate debt securities

    53,405        2,414        (64     55,755        23,255   

Equity and debt mutual funds

    8,767        961        (11     9,717        600   

Certificates of deposit and time deposits

    1,627                    1,627         

Non-U.S. government securities

    84                    84         
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  $ 663,625      $ 3,862      $ (99   $ 667,388      $ 59,100   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Reported as follows:

 

     Cost      Unrealized
Gain
     Unrealized
(Loss)
    Fair Market
Value
     Fair Market
Value of Investments
with Unrealized Losses
 
     (in thousands)  

Marketable securities

   $ 431,324       $ 203       $ (11   $ 431,516       $ 41,110   

Long-term marketable securities

     232,301         3,659         (88     235,872         17,990   
  

 

 

    

 

 

    

 

 

   

 

 

    

 

 

 
   $ 663,625       $ 3,862       $ (99   $ 667,388       $ 59,100   
  

 

 

    

 

 

    

 

 

   

 

 

    

 

 

 

 

    December 31, 2011  
    Available-for-Sale     Fair Market
Value of Investments
with Unrealized  Losses
 
    Cost     Unrealized
Gain
    Unrealized
(Loss)
    Fair Market
Value
   
    (in thousands)  

U.S. government agency securities

  $ 83,070      $ 152      $ (25   $ 83,197      $ 28,510   

Corporate debt securities

    43,077        1,893        (141     44,829        17,033   

Commercial paper

    22,083        2        (10     22,075        9,479   

U.S. Treasury securities

    14,141        39              14,180         

Equity and debt mutual funds

    7,876        477        (116     8,237        3,749   

Certificates of deposit and time deposits

    8,122              (5     8,117        5,800   

Non-U.S. government securities

    256        18              274         
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  $ 178,625      $ 2,581      $ (297   $ 180,909      $ 64,571   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Reported as follows:

 

     Cost      Unrealized
Gain
     Unrealized
(Loss)
    Fair Market
Value
     Fair Market
Value of Investments
with Unrealized Losses
 
     (in thousands)  

Marketable securities

   $ 96,518       $ 24       $ (40   $ 96,502       $ 35,595   

Long-term marketable securities

     82,107         2,557         (257     84,407         28,976   
  

 

 

    

 

 

    

 

 

   

 

 

    

 

 

 
   $ 178,625       $ 2,581       $ (297   $ 180,909       $ 64,571   
  

 

 

    

 

 

    

 

 

   

 

 

    

 

 

 

As of December 31, 2012, the fair market value of investments with unrealized losses totaled $59.1 million. There were no unrealized losses greater than one year. As of December 31, 2011, the fair market value of investments with unrealized losses totaled $64.6 million. Of this value, $2.4 million had unrealized losses for greater than one year and $62.2 million had unrealized losses for less than one year. Teradyne reviews its investments to identify and evaluate investments that have an indication of possible impairment. Based on this review, Teradyne determined that the unrealized losses related to these investments, at December 31, 2012 and 2011, were temporary.

The contractual maturities of investments held at December 31, 2012 were as follows:

 

     Cost      Fair Value  
     (in thousands)  

Due within one year

   $ 431,324       $ 431,516   

Due after 1 year through 5 years

     208,754         209,902   

Due after 5 years through 10 years

     7,493         7,773   

Due after 10 years

     16,054         18,197   
  

 

 

    

 

 

 

Total

   $ 663,625       $ 667,388   
  

 

 

    

 

 

 

Derivatives

Teradyne conducts business in a number of foreign countries, with certain transactions denominated in local currencies. The purpose of Teradyne’s foreign currency management is to minimize the effect of exchange rate fluctuations on certain foreign currency denominated net monetary assets. Teradyne does not use derivative financial instruments for trading or speculative purposes.

To minimize the effect of exchange rate fluctuations associated with the remeasurement of net monetary assets denominated in foreign currencies, Teradyne enters into foreign currency forward contracts. The change in fair value of these derivatives is recorded directly in earnings, and is used to offset the change in value of the net monetary assets denominated in foreign currencies.

At December 31, 2012 and 2011, Teradyne had the following contracts to buy and sell non-U.S. currencies for U.S. dollars and other non-U.S. currencies with the following notional amounts:

 

     December 31, 2012     December 31, 2011  
     Buy
Position
    Sell
Position
     Net
Total
    Buy
Position
    Sell
Position
     Net
Total
 
     (in millions)  

Japanese Yen

   $     $ 36.3       $ 36.3      $     $ 50.8       $ 50.8   

Taiwan Dollar

            4.2         4.2        (0.8     6.3         5.5   

British Pound Sterling

           5.5         5.5              10.1         10.1   

Euro

     (16.8     1.3         (15.5     (15.2     2.1         (13.1
  

 

 

   

 

 

    

 

 

   

 

 

   

 

 

    

 

 

 

Total

   $ (16.8   $ 47.3       $ 30.5      $ (16.0   $ 69.3       $ 53.3   
  

 

 

   

 

 

    

 

 

   

 

 

   

 

 

    

 

 

 

The fair value of the outstanding contracts was a gain of $0.1 million and a loss of $0.3 million at December 31, 2012 and 2011, respectively.

In 2012, Teradyne recorded net realized gains of $4.0 million related to foreign currency forward contracts hedging net monetary positions. In 2011 and 2010, Teradyne recorded net realized losses of $1.3 million and $2.3 million, respectively, related to foreign currency forward contracts hedging net monetary positions. Gains and losses on foreign currency forward contracts and foreign currency remeasurement gains and losses on monetary assets and liabilities are included in interest expense and other.

The following table summarizes the fair value of derivative instruments as of December 31, 2012 and 2011:

 

    

Balance Sheet Location

   December 31,
2012
     December 31,
2011
 
          (in thousands)  

Derivatives not designated as hedging instruments:

        

Foreign exchange contracts

   Prepayments and other current assets    $ 121       $   

Foreign exchange contracts

   Other accrued liabilities              314   
     

 

 

    

 

 

 

Total derivatives

      $ 121       $ 314   
     

 

 

    

 

 

 

The following table summarizes the effect of derivative instruments in the statement of operations recognized for the years ended December 31, 2012, 2011 and 2010 (the table does not reflect the corresponding gain (loss) from the remeasurement of the balance sheet):

 

     Location of Gains (Losses)
Recognized in Statement
of Operations
     December 31,
2012
     December 31,
2011
    December 31,
2010
 
            (in thousands)  

Derivatives not designated as hedging instruments:

          

Foreign exchange contracts

     Interest expense and other       $ 3,974       $ (1,327   $ (2,289
     

 

 

    

 

 

   

 

 

 

Total derivatives

      $ 3,974       $ (1,327   $ (2,289
     

 

 

    

 

 

   

 

 

 

See Note I: “Debt” regarding derivatives related to the convertible senior notes.

 

Concentration of Credit Risk

Financial instruments which potentially subject Teradyne to concentrations of credit risk consist principally of cash equivalents, marketable securities, forward currency contracts and accounts receivable. Teradyne’s cash equivalents consist primarily of money market funds invested in U.S. Treasuries and government agencies. Teradyne’s fixed income available-for-sale marketable securities have a minimum rating of AA by one or more of the major credit rating agencies. Teradyne places foreign currency forward contracts with high credit-quality financial institutions in order to minimize credit risk exposure. Concentrations of credit risk with respect to accounts receivable are limited due to the large number of geographically dispersed customers. Teradyne performs ongoing credit evaluations of its customers’ financial condition and from time to time may require customers to provide a letter of credit from a bank to secure accounts receivable.